Queench, Inc. announces the completion of a change of control with KRTL Biotech, Inc. in which KRTL acquired voting control in a private transaction through Special Series A Preferred stock, acquired from Synergy Management and confirmation of QENC's business model shift to biotechnology. As part of the transaction, Kai Kim was appointed CEO/President of the company.